Association between the medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer

JAMA - Journal of the American Medical Association

Volumn 312, Issue 18, 2014, Pages 1888-1896

  Obermeyer, Ziad ^a,b   Makar, Maggie ^b   Abujaber, Samer ^b   Dominici, Francesca ^c   Block, Susan ^a,b,d   Cutler, David M ^e,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD UNIVERSITY   (United States)

^f NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PROGNOSIS; COHORT ANALYSIS; COMORBIDITY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOME CARE; HOSPICE CARE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MEDICARE; NEOPLASM; PROPENSITY SCORE; QUALITY OF LIFE; REIMBURSEMENT; SURVIVAL TIME; TERMINAL CARE; AGED; COMPARATIVE STUDY; ECONOMICS; FEMALE; HEALTH SERVICE; INTENSIVE CARE; MALE; MEDICAL FEE; NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEE-FOR-SERVICE PLANS; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HOSPICE CARE; HOSPITALIZATION; HUMANS; INTENSIVE CARE; MALE; MEDICARE; NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; TERMINAL CARE; UNITED STATES;

EID: 84918773392     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.14950     Document Type: Article

References (25)

1. Barnato AE, McClellan MB, Kagay CR, Garber AM. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Serv Res. 2004;39(2):363-375.
2. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291(1):88-93.
3. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). JAMA. 1995;274(20):1591-1598.
4. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665-1673.
5. Steinhauser KE, Clipp EC, McNeilly M, Christakis NA, McIntyre LM, Tulsky JA. In search of a good death: observations of patients, families, and providers. Ann Intern Med. 2000;132(10):825-832.
6. Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. http://www.nap.edu/openbook.php?record-id=18748. Published September 2014. Accessed September 26, 2014.
7. Teno JM, Gozalo PL, Bynum JPW, et al. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA. 2013;309(5):470-477.
8. National Hospice and Palliative Care Organization. NHPCO facts and figures: hospice care in America. http://www.nhpco.org/sites/default/files/public/Statistics-Research/2012-Facts-Figures.pdf. Published November 2012. Accessed July 23, 2013.
9. Huskamp HA, Buntin MB, Wang V, Newhouse JP. Providing care at the end of life: do Medicare rules impede good care? Health Aff (Millwood). 2001;20 (3):204-211.
10. Kelley AS, Deb P, Du Q, Aldridge Carlson MD, Morrison RS. Hospice enrollment saves money for Medicare and improves care quality across a number of different lengths-of-stay. Health Aff (Millwood). 2013;32(3):552-561.
11. Tinetti ME. The retreat from advanced care planning. JAMA. 2012;307(9):915-916.
12. Casarett DJ. Rethinking hospice eligibility criteria. JAMA. 2011;305(10):1031-1032.
13. Harrington SE, Smith TJ. The role of chemotherapy at the end of life: "when is enough, enough?" JAMA. 2008;299(22):2667-2678.
14. Meier DE. Increased access to palliative care and hospice services: opportunities to improve value in health care. Milbank Q. 2011;89(3):343-380.
15. Taylor DH Jr, Ostermann J, Van Houtven CH, Tulsky JA, Steinhauser K. What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program? Soc Sci Med. 2007;65(7):1466-1478.
16. Glare P, Christakis NA. Prognosis in Advanced Cancer. New York,NY: Oxford University Press; 2008.
17. Wennberg JE, Staiger DO, Sharp SM, et al. Observational intensity bias associated with illness adjustment: cross sectional analysis of insurance claims. BMJ. 2013;346:f549.
18. Iacus SM, King G, Porro G. Multivariate matching methods that are monotonic imbalance bounding. J AmStat Assoc. doi:10.1198/jasa.2011.tm09599.
19. Du XL, Key CR, Dickie L, Darling R, Geraci JM, Zhang D. External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews. Med Care. 2006;44(2):124-131.
20. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002;40(8)(suppl):IV-55-IV-61.
21. Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011;64(7):749-759.
22. Research Data Assistance Center. CMMI-payment bundling initiative. http://www.resdac.org/sites/resdac.org/files/CMMI-FAQs.pdf. Updated April 2012. Accessed July 23, 2013.
23. Institute of Medicine of the National Academies. Geographic variation in health care spending and promotion of high-value care - interim report. http://www.iom.edu/Reports/2013/Geographic-Variation-in-Health-Care-Spending-and-Promotion-of-High-Care-Value-Interim-Report.aspx. Published March 2013. Accessed July 23, 2013.
24. Bogasky S, Sheingold S, Stearns SC. Medicare's hospice benefit: analysis of utilization and resource use. Medicare Medicaid Res Rev. 2014;4(2):1-14.
25. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007;17(8):584-590.